Lipodystrophia centrifugalis abdominals infantilis presenting as a giant ulceration and treatment with hydroxychloroquine and baricitinib
Indian Journal of Dermatology, Venereology and Leprology · 2024
DOI: 10.25259/ijdvl_643_2023 ↗Kurz gefasst
Fallbericht in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2024. Verfasst von Xinrong Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Xicheng, Beijing, China. Hauptthemen laut MEDLINE: Pyrazoles, Hydroxychloroquine, Sulfonamides, Azetidines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Xicheng, Beijing, China.
Zitieren
APA
Zhao, X., Miao, C., Chen, Y., Xiang, X., Liu, Y., Zhaoyang, W., & Xu, Z. (2024). Lipodystrophia centrifugalis abdominals infantilis presenting as a giant ulceration and treatment with hydroxychloroquine and baricitinib. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_643_2023
Vancouver
Zhao X, Miao C, Chen Y, Xiang X, Liu Y, Zhaoyang W, et al. Lipodystrophia centrifugalis abdominals infantilis presenting as a giant ulceration and treatment with hydroxychloroquine and baricitinib. Indian Journal of Dermatology, Venereology and Leprology. 2024. doi:10.25259/ijdvl_643_2023
BibTeX
@article{Zhao2024,
author = {Zhao, Xinrong and Miao, Chaoyang and Chen, Yunliu and Xiang, Xin and Liu, Yuanxiang and Zhaoyang, Wang and Xu, Zigang},
title = {Lipodystrophia centrifugalis abdominals infantilis presenting as a giant ulceration and treatment with hydroxychloroquine and baricitinib},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2024},
doi = {10.25259/ijdvl_643_2023}
}
EUVIMED